<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02152163</url>
  </required_header>
  <id_info>
    <org_study_id>WIRB Protocol #20121749</org_study_id>
    <nct_id>NCT02152163</nct_id>
  </id_info>
  <brief_title>Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients</brief_title>
  <official_title>Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Delray Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Delray Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      STUDY OBJECTIVES:

        1. To evaluate the effectiveness of around the clock (OTC) IV ibuprofen (8 doses) in
           decreasing pain in orthopedic trauma patients with fractures of the extremities, face,
           pelvis and/or ribs compared to patients not receiving the medication.

        2. To evaluate the effectiveness of around the clock (OTC) IV ibuprofen (8 doses) in
           decreasing the use of opioid analgesics among orthopedic trauma patients with fractures
           of the extremities, face, pelvis, and/or ribs compared to compared to patients not
           receiving the medication.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2012</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of IV Ibuprofen in orthropedic trauma patients</measure>
    <time_frame>Pain Scale End of Day 5</time_frame>
    <description>Pain will be measured using either a Visual Anolog Scale or a Numeric Rating Scales. A baseline pain score will be obtained prior to adminstration either placebo or IV ibuprofen. Pain assessements will be obtained from both groups 4hrs/2days and then twice daily for a total of 5days.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">99</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>IV Ibuprofen 800 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV Ibuprofen 800 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>IV Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Ibuprofen</intervention_name>
    <arm_group_label>IV Ibuprofen 800 mg</arm_group_label>
    <other_name>IV Caldolor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>IV Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Trauma patient admitted to Trauma ICU or Trauma Step-Down Units.

          2. Fracture of ribs, face, extremities and/or pelvis

          3. Age between 18 and 75 years old

          4. Adequate IV access

          5. Able to self report and communicate pain severity

        Exclusion Criteria:

          1. History of allergy or hypersensitivity to any component of IV Ibuprofen, aspirin (or
             aspirin related products) NSAIDs, or COX-2 inhibitors

          2. Any intracranial or spinal cord trauma

          3. History of clinically significant bleeding disorders including ITP, DIC or platelet
             dysfunction

          4. Recent history of intracranial surgery or stroke (within past 30 days)

          5. History of ulcers, gastritis or previous GI bleeding

          6. Renal Impairment (Creatinine &gt; 3.0 mg/dL)

          7. Pregnant or breastfeeding

          8. Otherwise unsuitable in the opinion of the treating physician at time of
             randomization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Russell Weisz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Delray Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Delray Medical Center</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2014</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Assessing the efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

